Anti Infective Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Global Anti-infective Drugs Market is Segmented by Product Type (Antibiotics, Antivirals, Antifungals, and Other Products), Indication (HIV Infection, Pneumonia, Respiratory Virus Infection, Sepsis, Tuberculosis, and Other Indications), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Other Distribution Channels), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Anti Infective Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Anti Infective Drugs Industry Overview

The anti-infective drugs market is competitive and consists of many global and local players. The market participants are actively launching new products and obtaining approvals for them, which is anticipated further to intensify the competitive environment within the studied market. Some key players in the anti-infective drugs market are Novartis AG, Merck & Co., Inc, Sanofi SA, GSK, and Gilead Sciences, among others.

Anti Infective Drugs Market Leaders

  1. Merck & Co., Inc

  2. Gilead Sciences

  3. GlaxoSmithKline PLC

  4. Pfizer Inc

  5. Novartis AG

  6. *Disclaimer: Major Players sorted in no particular order
Anti-infective Drugs Market Concentration